The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets - Uchida, S; Soshiroda, K; Okita, E (Eur J Pharmacol, 2015)
et al.